Europe Hair Loss Treatment Products Market

Europe Hair Loss Treatment Products Market Size (2024 to 2029)

The Europe hair loss treatment products market is expected to register a CAGR of 3.4% from 2024 to 2029 and be valued at USD 0.73 billion by 2029 from USD 0.62 billion in 2024.

Hair loss has become a typical concern among people with increasing pollution levels, work stress, and other medical conditions. To combat this issue, several methods were proposed such as the use of hair loss treatment products. These products are clinically tested and approved by dermatologists to be applied regularly. European consumers are among the significant contributors to hair loss treatment products.

One of the major driving factors propelling the growth of the European hair loss treatment products Market is the rising disposable income that led to increased purchasing power among local people. Changing fashion trends and a rise in awareness of the availability of new, more effective, and safer hair loss products across the region are also among the driving factors of the European Hair Loss Treatments Products business.

Increasing concerns among people regarding hair loss across the area especially among females are one of the major driving factors that help the market to grow further during the forecast period. As per the report, the market of hair loss treatment products in Europe is determined to increase much further owing to an aging population and the changing lifestyle of consumers in this area. Another significant driving factor of the European hair loss treatment products market is the high emphasis on appearances, increasing investments by the major players, and the increasing inclination towards origin-specific ingredients among the customers in different nations of this area.

The high cost of medication is one of the major restraints that is affecting the growth of the market of hair loss treatment products across the European region. Another considerable challenge to the growth of the market of hair loss treatment products is the presence of alternative treatment options such as hair transplant surgery, laser, light-based therapies, etc., which are proven to be effective.

Impact of COVID1-19 on the European hair loss treatment products market:

The coronavirus pandemic has affected business mainly by directly affecting production, creating supply chain disturbance and financial burden. This pandemic has impacted financially in every sector like restaurants, manufacturing units, flights, traveling, and so on to halt their services. Due to COVID-19, Europe Hair Loss Treatment Products Market is also facing difficulties as several manufacturing industries have stopped production due to the financial crisis they faced. As per the analysis, experts from the industry are predicting that the market will increase and will be back to the normal stage once the vaccine gets released. The local government has already lifted the lockdown in most countries and permitted manufacturing companies to start their businesses with strict rules and regulations.

This research report on the Europe hair loss treatment products market has been segmented and sub-segmented based on the following categories.

Europe Hair Loss Treatment Products Market – By Disease Type:

• Alopecia Areata
• Cicatricial Alopecia
• Traction Alopecia
• Alopecia Totalis
• Alopecia Universalis
• Androgenetic Alopecia
• Others

Europe Hair Loss Treatment Products Market – By Distribution Channel:

• Over-the-counter (OTC)
• Prescription-based

Among these, with the surge in online sales, the prescription-based segment is likely to hold the major share of the market in the foreseen years.

Europe Hair Loss Treatment Products Market – By End Use:

• Home Care settings
• Dermatology clinics
• Others

The dermatology clinics accounted for the prominent portion, which, however, is supposed to be dominated by homecare settings in the following years.

Europe Hair Loss Treatment Products Market – By Country:

• UK
• France
• Spain
• Germany
• Italy
• Russia
• Sweden
• Denmark
• Switzerland
• Netherlands
• Turkey
• Czech Republic
• Rest of Europe

Europe is expected to record an increase in the market share of Hair Loss treatment products owing to increased hair loss due to changing lifestyles and exposure to the environment, along with the growing popularity of brands in various countries such as Germany. The increasing consumer per capita spending is also estimated to propel the growth of the market of Hair Loss treatment products in Europe in terms of revenue rate in the next few years.

KEY MARKET PLAYERS:

Some of the key players operating in the European Hair Loss Treatments Products market are Concert Pharmaceuticals, Hcell Inc., Histogen Inc., Aclaris Therapeutics, Inc., Sun Pharmaceutical Industries Ltd, Merck & Co., Inc., Johnson & Johnson Services, Inc., and Glaxo Smith Kline Plc.